What is Edgewise Therapeutics, Inc.'s net change in cash?

Edgewise Therapeutics, Inc. (EWTX) reported net change in cash of -$27.94M in Q1 2026.

How has Edgewise Therapeutics, Inc.'s net change in cash changed year-over-year?

Edgewise Therapeutics, Inc.'s net change in cash decreased by 438.4% year-over-year, from $8.26M to -$27.94M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Edgewise Therapeutics, Inc. EWTX Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

CytokineticsCYTK

$7.32M+135%

PTC TherapeuticsPTCT

-$147.9M-121%

Catalyst PharmaceuticalCPRX

$46.69M-26.0%

Dyne Therapeutics, Inc.DYN

-$140.25M-481%

Viking TherapeuticsVKTX

-$47.71M-524%

Other financials

Income statement

See full

Operating income-$54.1M-17.7%

Net income-$49.0M-20.1%

EPS (diluted)-$0.46-7.0%

Balance sheet

See full

Cash & equivalents$33.2M-33.5%

Total debt$3.8M-16.8%

Total equity$493.2M+14.8%

Total assets$518.5M+14.1%

Cash flow

See full

Operating cash flow-$42.5M-12.4%

CapEx$260.0K+491%

Free cash flow-$42.8M-12.9%

Valuation

See full

Market cap$3.96B+61.3%

Enterprise value$3.93B+63.5%

Returns & leverage

See full

Return on equity-38.1%+13.4pp

Debt / equity0×0.0×

Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s net change in cash?: Edgewise Therapeutics, Inc. (EWTX) reported net change in cash of -$27.94M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s net change in cash changed year-over-year?: Edgewise Therapeutics, Inc.'s net change in cash decreased by 438.4% year-over-year, from $8.26M to -$27.94M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.